Skip to content
OpenCapital
Get started

Illumina ILMN Microarray — Total Revenue

Other segment segments

Sequencing
$995M+5.1%

Similar metrics at other companies

Azenta logo
AZTAMultiomics — Total Revenue
$63.7M+0.3%
10x Genomics, Inc. logo
TXGSingle Cell — Total Revenue
$90.8M-2.4%
Quanterix Corporation logo
QTRXSpatial Biology — Total revenues
$3.7M—
Pacific Biosciences of California logo
PACBInstrument revenue — Total Revenue
$9.72M-11.8%
Pacific Biosciences of California logo
PACBReportable Segment — Total Revenue
$37.18M+0.1%
Pacific Biosciences of California logo
PACBProduct revenue — Total Revenue
$31.53M+1.4%

Other financials

Income statement

See full
Revenue$1.1B+4.8%
Gross profit$721.0M+5.6%
Operating income$209.0M+27.4%
Net income$134.0M+2.3%
EPS (diluted)$0.87+6.1%

Balance sheet

See full
Cash & equivalents$1.1B-2.2%
Total debt$2.0B-3.0%
Total equity$2.7B+13.0%
Total assets$6.6B+6.1%

Cash flow

See full
Operating cash flow$289.0M+20.4%
CapEx$38.0M+18.8%
Free cash flow$251.0M+20.7%

Valuation

See full
Market cap$26.6B+91.5%
Enterprise value$27.56B+83.6%
P/E31.2×+20.1×
P/S6.1×+2.8×

Profitability

See full
Gross margin66.2%-0.1pp
Operating margin19.4%—
Net margin19.4%+12.7pp
FCF margin22.2%+2.0pp

Returns & leverage

See full
Return on equity33.8%+23.9pp
Debt / equity0.8×-0.1×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's microarray — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's microarray — total revenue?
Illumina (ILMN) reported microarray — total revenue of $96M in Q1 2026.
How has Illumina's microarray — total revenue changed year-over-year?
Illumina's microarray — total revenue increased by 2.1% year-over-year, from $94M to $96M.
What is the long-term trend for Illumina's microarray — total revenue?
Over 4 years (2021 to 2025), Illumina's microarray — total revenue has grown at a -3.8% compound annual growth rate (CAGR), from $417M to $357M.
What does microarray — total revenue mean?
This metric represents the total gross revenue generated from the sale of microarray-based products and associated services within a specific business segment. It reflects the market demand for genetic analysis tools that utilize microarray technology for high-throughput genotyping and gene expression profiling. This figure serves as a primary indicator of the segment's contribution to the overall corporate top-line performance.